Walker CL - Search Results

1

Uterine fibroids: the elephant in the room.

Walker CL, Stewart EA. Walker CL, et al. Science. 2005 Jun 10;308(5728):1589-92. doi: 10.1126/science.1112063. Science. 2005. PMID: 15947177 Review.

2

Estrogen/antiestrogen responsiveness in an in vivo/in vitro model for myometrial tumorigenesis.

Howe SR, Everitt JI, Gottardis MM, Walker C. Howe SR, et al. Ann N Y Acad Sci. 1995 Jun 12;761:373-5. doi: 10.1111/j.1749-6632.1995.tb31396.x. Ann N Y Acad Sci. 1995. PMID: 7625739 No abstract available.

3

Regulation of apoptosis in uterine leiomyomata.

Burroughs KD, Kiguchi K, Howe SR, Fuchs-Young R, Trono D, Barrett JC, Walker C. Burroughs KD, et al. Endocrinology. 1997 Jul;138(7):3056-64. doi: 10.1210/endo.138.7.5273. Endocrinology. 1997. PMID: 9202252

4

Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma.

Walker CL, Burroughs KD, Davis B, Sowell K, Everitt JI, Fuchs-Young R. Walker CL, et al. J Soc Gynecol Investig. 2000 Jul-Aug;7(4):249-56. J Soc Gynecol Investig. 2000. PMID: 10964025

5

Influence of exogenous estrogen receptor ligands on uterine leiomyoma: evidence from an in vitro/in vivo animal model for uterine fibroids.

Hunter DS, Hodges LC, Eagon PK, Vonier PM, Fuchs-Young R, Bergerson JS, Walker CL. Hunter DS, et al. Among authors: walker cl. Environ Health Perspect. 2000 Oct;108 Suppl 5:829-34. doi: 10.1289/ehp.00108s5829. Environ Health Perspect. 2000. PMID: 11035990 Free article. Review.

6

Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat.

Burroughs KD, Fuchs-Young R, Davis B, Walker CL. Burroughs KD, et al. Among authors: walker cl. Biol Reprod. 2000 Nov;63(5):1322-30. doi: 10.1095/biolreprod63.5.1322. Biol Reprod. 2000. PMID: 11058535

7

Uterine leiomyomas: mechanisms of tumorigenesis.

Houston KD, Hunter DS, Hodges LC, Walker CL. Houston KD, et al. Among authors: walker cl. Toxicol Pathol. 2001 Jan-Feb;29(1):100-4. doi: 10.1080/019262301301418900. Toxicol Pathol. 2001. PMID: 11215673 Review.

8

Protective effect of pregnancy for development of uterine leiomyoma.

Walker CL, Cesen-Cummings K, Houle C, Baird D, Barrett JC, Davis B. Walker CL, et al. Carcinogenesis. 2001 Dec;22(12):2049-52. doi: 10.1093/carcin/22.12.2049. Carcinogenesis. 2001. PMID: 11751438

9

An in vivo/in vitro model to assess endocrine disrupting activity of xenoestrogens in uterine leiomyoma.

Hodges LC, Hunter DS, Bergerson JS, Fuchs-Young R, Walker CL. Hodges LC, et al. Among authors: walker cl. Ann N Y Acad Sci. 2001 Dec;948:100-11. doi: 10.1111/j.1749-6632.2001.tb03991.x. Ann N Y Acad Sci. 2001. PMID: 11795388 Review.

10

Role of hormonal and reproductive factors in the etiology and treatment of uterine leiomyoma.

Walker CL. Walker CL. Recent Prog Horm Res. 2002;57:277-94. doi: 10.1210/rp.57.1.277. Recent Prog Horm Res. 2002. PMID: 12017548 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters